Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 22;10(11):2117.
doi: 10.3390/healthcare10112117.

Development and Validation of the First Smart TV-Based Visual Acuity Test: A Prospective Study

Affiliations

Development and Validation of the First Smart TV-Based Visual Acuity Test: A Prospective Study

Georgios Labiris et al. Healthcare (Basel). .

Abstract

(1) Background: While smartphones are among the primary devices used in telemedical applications, smart TV healthcare apps are not prevalent despite smart TVs' penetrance in home settings. The present study's objective was to develop and validate the first smart TV-based visual acuity (VA) test (Democritus Digital Visual Acuity Test (DDiVAT)) that allows a reliable VA self-assessment. (2) Methods: This is a prospective validation study. DDiVAT introduces several advanced features for reliable VA self-testing; among them: automatic calibration, voice recognition, voice guidance, automatic calculation of VA indexes, and a smart TV-based messaging system. Normal and low vision participants were included in the validation. DDiVAT VA results (VADDiVAT) were compared against the ones from: (a) the gold-standard conventional ETDRS (VAETDRS), and, (b) an independent ophthalmologist who monitored the self-examination testing (VARES). Comparisons were performed by noninferiority test (set at 2.5-letters) and intraclass correlation coefficients (ICCs). DDiVAT's test-retest reliability was assessed within a 15-day time-window. (3) Results: A total of 300 participants (185 and 115 with normal and low vision, respectively) responded to ETDRS and DDiVAT. Mean difference in letters was -0.05 for VAETDRS-VARES, 0.62 for VARES-VADDiVAT, and 0.67 for VAETDRS-VADDiVAT, significantly lower than the 2.5 letter noninferiority margin. ICCs indicated an excellent level of agreement, collectively and for each group (0.922-0.996). All displayed letters in DDiVAT presented a similar difficulty. The overall accuracy of the voice recognition service was 96.01%. ICC for VADDiVAT test-retest was 0.957. (4) Conclusions: The proposed DDiVAT presented non-significant VA differences with the ETDRS, suggesting that it can be used for accurate VA self-assessment in telemedical settings, both for normal and low-vision patients.

Keywords: home; smart TV; smartphone; telemedicine; validation; visual acuity test.

PubMed Disclaimer

Conflict of interest statement

The present study was funded by a research grant from Bayer Hellas. The supporting source had no involvement or restrictions in study design, collection, analysis, and interpretation of data or writing of the paper. The authors declared no potential conflict of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1
Figure 1
DDiVAT System-as-a-Service (SAS) explained.
Figure 2
Figure 2
DDiVAT’s unified modeling language (UML) diagram for the voice recognition service.
Figure 3
Figure 3
DDiVAT Control Flow chart.
Figure 4
Figure 4
DDiVAT color-based navigation: (a) DDiVAT smart TV-app; (b) Smart TV remote control; (c) DDiVAT SP-app.
Figure 5
Figure 5
logMAR 1 verification step: (a) DDiVAT’s TV-app verification screen; (b) DDiVAT’s SP-app verification screen.
Figure 6
Figure 6
Bland-Altman plots comparing VAETDRS and VARES in NVG (blue) and LVG (red).
Figure 7
Figure 7
Bland-Altman plots comparing VAETDRS and VADDiVAT in NVG (blue) and LVG (red).
Figure 8
Figure 8
Bland-Altman plots comparing VARES and VADDiVAT in NVG (blue) and LVG (red).
Figure 9
Figure 9
Noninferiority analysis (95% CI and mean difference value as “*”, using a 2.5-letter margin), of VAETDRS vs. VARES (denoted as “∆”), VAETDRS vs. VADDiVAT (denoted as “o”), and VARES vs. VADDiVAT (denoted as “□”) for NVG (black), LVG (red), and all patients (blue).
Figure 10
Figure 10
Confusion matrix of the letters displayed in DDiVAT’s TV-app (LettersTV) versus the letters read by the participants (LettersPar).
Figure 11
Figure 11
Percentage of correct identification for each letter by the examinees.
Figure 12
Figure 12
Confusion matrix of the letters read by participants (LettersPar) versus the letters recognized by the smartphone (LettersDDiVAT).
Figure 13
Figure 13
Percentage of letters correctly identified by the voice recognition service (sensitivity). The number of each letter’s appearance is shown at the top of each column. Blue bars: Latin letters used in the test and appearing in TV-app; orange bars: letters not included in the test, thus not appearing in TV-app.
None

References

    1. GBD 2019 Blindness and Vision Impairment Collaborators, Vision Loss Expert Group of the Global Burden of Disease Study Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: The Right to Sight: An analysis for the Global Burden of Disease Study. Lancet Glob. Health. 2021;9:e144–e160. doi: 10.1016/S2214-109X(20)30489-7. - DOI - PMC - PubMed
    1. Gopalakrishnan S., Velu S., Raman R. Low-vision intervention in individuals with age-related macular degeneration. Indian J. Ophthalmol. 2020;68:886–889. doi: 10.4103/ijo.IJO_1093_19. - DOI - PMC - PubMed
    1. Brown M.M., Brown G.C., Sharma S., Landy J., Bakal J. Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration. Arch. Ophthalmol. 2002;120:481–484. doi: 10.1001/archopht.120.4.481. - DOI - PubMed
    1. Shah V.A., Gupta S.K., Shah K.V., Vinjamaram S., Chalam K.V. TTO utility scores measure quality of life in patients with visual morbidity due to diabetic retinopathy or ARMD. Ophthalmic Epidemiol. 2004;11:43–51. doi: 10.1076/opep.11.1.43.26436. - DOI - PubMed
    1. Labiris G., Panagiotopoulou E.K., Kozobolis V.P. A systematic review of teleophthalmological studies in Europe. Int. J. Ophthalmol. 2018;11:314–325. doi: 10.18240/ijo.2018.02.22. - DOI - PMC - PubMed

Grants and funding

LinkOut - more resources